22-50776706-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001130919.3(RABL2B):c.181C>T(p.His61Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000203 in 1,611,666 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001130919.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RABL2B | NM_001130919.3 | c.181C>T | p.His61Tyr | missense_variant | 4/9 | ENST00000691320.1 | NP_001124391.1 | |
RPL23AP82 | NR_026981.1 | n.242-6414G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RABL2B | ENST00000691320.1 | c.181C>T | p.His61Tyr | missense_variant | 4/9 | NM_001130919.3 | ENSP00000509250 | A2 | ||
RPL23AP7 | ENST00000496652.5 | n.380-6414G>A | intron_variant, non_coding_transcript_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152186Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.000182 AC: 45AN: 247124Hom.: 0 AF XY: 0.000210 AC XY: 28AN XY: 133506
GnomAD4 exome AF: 0.000217 AC: 316AN: 1459480Hom.: 2 Cov.: 31 AF XY: 0.000245 AC XY: 178AN XY: 725776
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152186Hom.: 0 Cov.: 30 AF XY: 0.0000807 AC XY: 6AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.181C>T (p.H61Y) alteration is located in exon 5 (coding exon 3) of the RABL2B gene. This alteration results from a C to T substitution at nucleotide position 181, causing the histidine (H) at amino acid position 61 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at